Camber Pharmaceuticals, Inc. recalls Camber Pharmaceuticals, Inc. — Losartan Tablets USP 25 mg, 50 mg, and 100 mg
- Recall date
- February 28, 2019
- Source
- U.S. Food & Drug Administration (FDA) — recall announcement
- Brand / firm
- Camber Pharmaceuticals, Inc., Camber Pharmaceuticals, Inc.
Why it was recalled
Due to The Detection of N-Nitroso N-Methyl 4-Amino Butyric Acid (NMBA) — Unapproved Ingredient
What was recalled
Losartan Tablets USP 25 mg, 50 mg, and 100 mg
Read the official recall notice →
Get recall alerts
Free email alert whenever Camber Pharmaceuticals, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Camber Pharmaceuticals, Inc., Camber Pharmaceuticals, Inc.